Hans E. Bishop to Join Agilent’s Board of Directors
CEO of Juno Therapeutics brings deep knowledge of the biopharma industry SANTA CLARA, Calif., July 18, 2017 Agilent Technologies, Inc. (NYSE: A) today announced that Hans E. Bishop, CEO of Juno Therapeutics, has been elected to its board of directors. Bishop co-founded Juno Therapeutics, a Seattle-based biopharmaceutical company, in 2013. As president and CEO, Bishop... Read more